Med-Chemist : "Quintessential Medicinal Chemistry"
Tuesday, July 17, 2012
USPTO issues patent to MicuRx’s MRX-I antibacterial agent
›
USPTO issues patent to MicuRx’s MRX-I antibacterial agent : MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company devel...
Monday, July 16, 2012
Azithromycin can be effective treatment option for patients with BOS
›
In continuation of my update on azithromycin Azithromycin can be effective treatment option for patients with BOS : Researchers in th...
Sunday, July 15, 2012
Positive Results from Tesetaxel Study
›
Genta Incorporated announced results from its Phase 2 clinical trial using tesetaxel as initial, single-agent chemotherapy in women w...
Saturday, July 14, 2012
Tivantinib Meets Study Endpoint
›
ArQule Inc . and Daiichi Sankyo Co. Ltd. announced that a Phase 2 trial data using tivantinib as a single agent investigational second-...
Friday, July 13, 2012
New anti-cancer drug developed
›
New anti-cancer drug developed
Wednesday, July 11, 2012
Successful Completion Of Proof-of-concept Clinical Trial Of Levotofisopam For The Treatment Of Gout
›
Pharmos Corporation , announced that it has successfully completed a proof-of-concept clinical trial using its compound levotofisopam (5...
Monday, July 9, 2012
Achillion Announces Additional Proof-of-Concept Data With ACH-2684 for the Treatment of Hepatitis C
›
Achillion Announces Additional Proof-of-Concept Data With ACH-2684 for the Treatment of Hepatitis C : Achieves Up to 3.73 log10 Reduction ...
Sunday, July 8, 2012
Heparin-like compounds inhibit breast cancer metastasis to bone
›
Heparin-like compounds inhibit breast cancer metastasis to bone : Researchers from VTT Technical Research Centre of Finland have in collab...
Saturday, July 7, 2012
NSAIDs and Cardiovascular Risk Explained, According to Studies from the Perelman School of Medicine
›
NSAIDs and Cardiovascular Risk Explained, According to Studies from the Perelman School of Medicine : After nearly 13 years of study and i...
Friday, July 6, 2012
A high-throughput drug screen for Entamoeba histolytica identifies a new lead and target
›
Research by a collaborative group of scientists from UC San Diego School of Medicine, UC San Francisco and Wake Forest School of Medicine...
Thursday, July 5, 2012
Study shows how a drug-lead compound suppresses tumour formation
›
Study shows how a drug-lead compound suppresses tumour formation : A team of scientists from the National University of Singapore's (N...
Wednesday, July 4, 2012
Scientists unravel action mechanism of castor oil
›
Scientists unravel action mechanism of castor oil : Castor oil is known primarily as an effective laxative; however, it was also used in a...
Tuesday, July 3, 2012
New Blood Thinner May Lower Chances of Clots in High-Risk Heart Patients: FDA
›
In continuation of my update on Rivaroxaban New Blood Thinner May Lower Chances of Clots in High-Risk Heart Patients: FDA : The new ...
Monday, July 2, 2012
Cobiprostone shows promise against NSAID-induced gastric mucosal injury
›
Cobiprostone shows promise against NSAID-induced gastric mucosal injury : Sucampo Pharmaceuticals, Inc. today announced the presentation o...
Sunday, July 1, 2012
Pernix Therapeutics introduces Omeclamox-Pak® for the treatment of H. pylori infection and duodenal ulcer disease
›
Pernix Therapeutics introduces Omeclamox-Pak® for the treatment of H. pylori infection and duodenal ulcer disease : Pernix Therapeutics Ho...
‹
›
Home
View web version